Plasma s<scp>RAGE</scp> and <scp>N</scp>‐(carboxymethyl) lysine in patients with <scp>CHF</scp> and/or <scp>COPD</scp>

Abstract

Plasma levels of sRAGE and CML are increased in CHF, but not in COPD patients. The robust association between NT-pro BNP, a diagnostic and prognostic marker in CHF, and sRAGE concentrations might suggest a possible BNP pathway of amplification of inflammation via the AGE/RAGE system.